219 related articles for article (PubMed ID: 15545599)
21. Transgene-mediated hyper-expression of IL-5 inhibits autoimmune disease but increases the risk of B cell chronic lymphocytic leukemia in a model of murine lupus.
Wen X; Zhang D; Kikuchi Y; Jiang Y; Nakamura K; Xiu Y; Tsurui H; Takahashi K; Abe M; Ohtsuji M; Nishimura H; Takatsu K; Shirai T; Hirose S
Eur J Immunol; 2004 Oct; 34(10):2740-9. PubMed ID: 15368290
[TBL] [Abstract][Full Text] [Related]
22. Chronic lymphocytic leukemia modeled in mouse by targeted miR-29 expression.
Santanam U; Zanesi N; Efanov A; Costinean S; Palamarchuk A; Hagan JP; Volinia S; Alder H; Rassenti L; Kipps T; Croce CM; Pekarsky Y
Proc Natl Acad Sci U S A; 2010 Jul; 107(27):12210-5. PubMed ID: 20566844
[TBL] [Abstract][Full Text] [Related]
23. Apoptosis induction by hypercross-linking of the surface antigen CD5 with anti-CD5 monoclonal antibodies in B cell chronic lymphocytic leukemia.
Cioca DP; Kitano K
Leukemia; 2002 Mar; 16(3):335-43. PubMed ID: 11896536
[TBL] [Abstract][Full Text] [Related]
24. Large cell variants of CD5+, CD23- B-cell lymphoma/leukemia.
Dunphy CH; Perkins SL
Arch Pathol Lab Med; 2001 Apr; 125(4):513-8. PubMed ID: 11260626
[TBL] [Abstract][Full Text] [Related]
25. Interaction with vascular endothelium enhances survival in primary chronic lymphocytic leukemia cells via NF-kappaB activation and de novo gene transcription.
Buggins AG; Pepper C; Patten PE; Hewamana S; Gohil S; Moorhead J; Folarin N; Yallop D; Thomas NS; Mufti GJ; Fegan C; Devereux S
Cancer Res; 2010 Oct; 70(19):7523-33. PubMed ID: 20736369
[TBL] [Abstract][Full Text] [Related]
26. TNFR-associated factor family protein expression in normal tissues and lymphoid malignancies.
Zapata JM; Krajewska M; Krajewski S; Kitada S; Welsh K; Monks A; McCloskey N; Gordon J; Kipps TJ; Gascoyne RD; Shabaik A; Reed JC
J Immunol; 2000 Nov; 165(9):5084-96. PubMed ID: 11046039
[TBL] [Abstract][Full Text] [Related]
27. CD11c (LEU-M5) expression characterizes a B-cell chronic lymphoproliferative disorder with features of both chronic lymphocytic leukemia and hairy cell leukemia.
Hanson CA; Gribbin TE; Schnitzer B; Schlegelmilch JA; Mitchell BS; Stoolman LM
Blood; 1990 Dec; 76(11):2360-7. PubMed ID: 1701669
[TBL] [Abstract][Full Text] [Related]
28. IgVH mutational status and clonality analysis of Richter's transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution.
Mao Z; Quintanilla-Martinez L; Raffeld M; Richter M; Krugmann J; Burek C; Hartmann E; Rudiger T; Jaffe ES; Müller-Hermelink HK; Ott G; Fend F; Rosenwald A
Am J Surg Pathol; 2007 Oct; 31(10):1605-14. PubMed ID: 17895764
[TBL] [Abstract][Full Text] [Related]
29. Characteristics of CD11c+CD5+ chronic B-cell leukemias and the identification of novel peripheral blood B-cell subsets with chronic lymphoid leukemia immunophenotypes.
Wormsley SB; Baird SM; Gadol N; Rai KR; Sobol RE
Blood; 1990 Jul; 76(1):123-30. PubMed ID: 1694698
[TBL] [Abstract][Full Text] [Related]
30. Adhesion to bone marrow stroma inhibits apoptosis of chronic lymphocytic leukemia cells.
Lagneaux L; Delforge A; De Bruyn C; Bernier M; Bron D
Leuk Lymphoma; 1999 Nov; 35(5-6):445-53. PubMed ID: 10609782
[TBL] [Abstract][Full Text] [Related]
31. The chemokine receptor CXCR3 is expressed in a subset of B-cell lymphomas and is a marker of B-cell chronic lymphocytic leukemia.
Jones D; Benjamin RJ; Shahsafaei A; Dorfman DM
Blood; 2000 Jan; 95(2):627-32. PubMed ID: 10627472
[TBL] [Abstract][Full Text] [Related]
32. Lack of intraclonal diversification in Ig heavy and light chain V region genes expressed by CD5+IgM+ chronic lymphocytic leukemia B cells: a multiple time point analysis.
Schettino EW; Cerutti A; Chiorazzi N; Casali P
J Immunol; 1998 Jan; 160(2):820-30. PubMed ID: 9551917
[TBL] [Abstract][Full Text] [Related]
33. Monoclonal B-cell lymphocytosis in the bone marrow: revisiting the criteria for chronic lymphocytic leukemia/small lymphocytic lymphoma.
Ryder CB; Oduro KA; Moore EM
Hum Pathol; 2022 Jul; 125():108-116. PubMed ID: 35472399
[TBL] [Abstract][Full Text] [Related]
34. Histogenesis and pathogenesis of follicular small cleaved cell lymphoma (FSCCL), diffuse small cleaved cell lymphoma (DSCCL) and intermediate lymphocytic lymphoma/lymphocytic lymphoma of intermediate differentiation (ILL/IDL).
Abe M; Wakasa H
Fukushima J Med Sci; 1994 Dec; 40(2):85-101. PubMed ID: 7642169
[TBL] [Abstract][Full Text] [Related]
35. Phenotypic markers and BCL-1 gene rearrangements in B-cell chronic lymphocytic leukemia: a Cancer and Leukemia Group B study.
Newman RA; Peterson B; Davey FR; Brabyn C; Collins H; Brunetto VL; Duggan DB; Weiss RB; Royston I; Millard FE
Blood; 1993 Aug; 82(4):1239-46. PubMed ID: 8102560
[TBL] [Abstract][Full Text] [Related]
36. TCR-independent killing of B cell malignancies by anti-third-party CTLs: the critical role of MHC-CD8 engagement.
Lask A; Goichberg P; Cohen A; Goren-Arbel R; Milstein O; Aviner S; Feine I; Ophir E; Reich-Zeliger S; Hagin D; Klein T; Nagler A; Berrebi A; Reisner Y
J Immunol; 2011 Aug; 187(4):2006-14. PubMed ID: 21753148
[TBL] [Abstract][Full Text] [Related]
37. Phenotypic analysis of receptor-ligand pairs on B-cells in B-chronic lymphocytic leukemia.
Gagro A; Dasić G; Sabioncello A; Rabatić S; Reckzeh B; Havemann K; Kardum I; Jacksić B; Vitale B
Leuk Lymphoma; 1997 Apr; 25(3-4):301-11. PubMed ID: 9168440
[TBL] [Abstract][Full Text] [Related]
38. TRAF2/3 deficient B cells resist DNA damage-induced apoptosis via NF-κB2/XIAP/cIAP2 axis and IAP antagonist sensitizes mutant lymphomas to chemotherapeutic drugs.
Vashisht M; Ge H; John J; McKelvey HA; Chen J; Chen Z; Wang JH
Cell Death Dis; 2023 Sep; 14(9):599. PubMed ID: 37679334
[TBL] [Abstract][Full Text] [Related]
39. Primary cutaneous marginal zone B-cell lymphoma: a recently described entity of low-grade malignant cutaneous B-cell lymphoma.
Cerroni L; Signoretti S; Höfler G; Annessi G; Pütz B; Lackinger E; Metze D; Giannetti A; Kerl H
Am J Surg Pathol; 1997 Nov; 21(11):1307-15. PubMed ID: 9351568
[TBL] [Abstract][Full Text] [Related]
40. Mediation of apoptosis by and antitumor activity of lumiliximab in chronic lymphocytic leukemia cells and CD23+ lymphoma cell lines.
Pathan NI; Chu P; Hariharan K; Cheney C; Molina A; Byrd J
Blood; 2008 Feb; 111(3):1594-602. PubMed ID: 18032710
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
